SHERWIN STEPHEN A
SEC CIK 1079462 · EDGAR
BoughtSold
Most active insiders at NBIX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | GORMAN KEVIN CHARLES | Dir | — | $37.82M |
| 2 | Cooke Julie | CHRO | — | $5.77M |
| 3 | Gano Kyle | CEO, Dir | — | $4.87M |
| 4 | Lippoldt Darin | CLO | — | $4.20M |
| 5 | SHERWIN STEPHEN A | Dir | — | $4.13M |
| 6 | Delaet Ingrid | Chief Regulatory Off | — | $3.75M |
| 7 | Onyia Jude | CSO | — | $3.47M |
| 8 | RASTETTER WILLIAM H | Dir | — | $2.73M |
| 9 | POPS RICHARD F | Dir | — | $2.36M |
| 10 | LYONS GARY A | Dir | — | $2.29M |
Transactions 24
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-03 21:39 | 2026-09-02 | NBIX | NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A | Dir | G - Gift | $0.00 | -1,000 | 14.9K | -6% | $0 | |
| 2026-06-11 17:47 | 2026-06-09 | BIIB | Biogen | SHERWIN STEPHEN A | Dir | A - Grant | $0.00 | +1,505 | 15.2K | +11% | $0 | |
| DMT | 2026-06-09 17:40 | 2026-06-05 | NBIX | NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A | Dir | M - OptEx | $64.10 | +25.0K | 40.9K | +158% | +$1.60M |
| DMT | 2026-06-09 17:40 | 2026-06-05 | NBIX | NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A | Dir | S - Sale+OE | $165.32 | -25.0K | 15.9K | -61% | -$4.13M |
| D | 2026-05-21 19:24 | 2026-05-21 | NBIX | NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A | Dir | M - OptEx | $0.00 | +3,318 | 15.9K | +26% | $0 |
| 2025-09-03 | 2025-09-02 | NBIX | NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A | Dir | G - Gift | $0.00 | -1,000 | 12.5K | -7% | $0 | |
| 2025-06-18 | 2025-06-17 | BIIB | Biogen | SHERWIN STEPHEN A | Dir | A - Grant | $0.00 | +2,370 | 13.7K | +21% | $0 | |
| D | 2025-05-22 | 2025-05-22 | NBIX | NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A | Dir | M - OptEx | $0.00 | +2,869 | 13.5K | +27% | $0 |
| 2025-03-10 | 2025-03-07 | BIIB | Biogen | SHERWIN STEPHEN A | Dir | S - Sale | $150.02 | -8,760 | 11.3K | -44% | -$1.31M | |
| 2025-02-14 | 2025-02-13 | NBIX | NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A | Dir | S - Sale | $116.69 | -13.8K | 10.7K | -56% | -$1.61M | |
| 2024-11-07 | 2024-11-04 | NBIX | NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A | Dir | G - Gift | $0.00 | -2,000 | 24.5K | -8% | $0 | |
| 2024-06-25 | 2024-06-21 | BIIB | Biogen | SHERWIN STEPHEN A | Dir | A - Grant | $0.00 | +1,340 | 20.1K | +7% | $0 | |
| DM | 2024-05-30 | 2024-05-29 | NBIX | NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A | Dir | M - OptEx | $44.68 | +40.0K | 41.5K | +2,660% | +$1.79M |
| DM | 2024-05-30 | 2024-05-29 | NBIX | NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A | Dir | S - Sale+OE | $133.46 | -40.0K | 26.5K | -60% | -$5.34M |
| D | 2024-05-21 | 2024-05-17 | NBIX | NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A | Dir | M - OptEx | $0.00 | +4,199 | 26.5K | +19% | $0 |
| 2023-11-20 | 2023-11-16 | NBIX | NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A | Dir | G - Gift | $0.00 | -2,750 | 22.3K | -11% | $0 | |
| 2023-06-28 | 2023-06-26 | BIIB | Biogen | SHERWIN STEPHEN A | Dir | A - Grant | $0.00 | +960 | 18.7K | +5% | $0 | |
| DM | 2023-01-05 | 2023-01-03 | NBIX | NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A | Dir | S - Sale+OE | $118.86 | -30.0K | 25.1K | -54% | -$3.57M |
| DM | 2023-01-05 | 2023-01-03 | NBIX | NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A | Dir | M - OptEx | $12.85 | +30.0K | 40.1K | +298% | +$385.4K |
| 2022-06-17 | 2022-06-15 | BIIB | Biogen | SHERWIN STEPHEN A | Dir | A - Grant | $0.00 | +1,370 | 18.5K | +8% | $0 | |
| D | 2022-01-26 | 2022-01-24 | NBIX | NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A | Dir | M - OptEx | $6.66 | +15.0K | 40.1K | +60% | +$99.9K |
| D | 2022-01-26 | 2022-01-24 | NBIX | NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A | Dir | S - Sale+OE | $74.43 | -15.0K | 25.1K | -37% | -$1.12M |
| 2021-12-16 | 2021-12-14 | NBIX | NEUROCRINE BIOSCIENCES INC | Dir | G - Gift | $0.00 | -2,000 | 25.1K | -7% | $0 | ||
| 2021-07-02 | 2021-07-01 | BIIB | Biogen | SHERWIN STEPHEN A | Dir | A - Grant | $0.00 | +775 | 17.1K | +5% | $0 |
Purchase Sale Sale after option exercise All abbreviations